ORTHOBLAST-II PASTE 02-2100-010

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,06,07,08,company represent report with the FDA on 2015-04-13 for ORTHOBLAST-II PASTE 02-2100-010 manufactured by Isotis Orthobiologics, Inc.

Event Text Entries

[5650110] It was reported that following an interbody fusion surgery osteolysis was found. The product was removed when osteolysis was found. It was reported the current opinion is the problem is not because of the orthoblast product. The pt was elderly, over 70 years old, and had combined orthopedic surgery (posterolateral fusion, interbody fusion with bone substitute). Add'l info has been requested.
Patient Sequence No: 1, Text Type: D, B5


[13130672] To date, the device involved in the reported incident has not been received for eval. An investigation has been initiated based upon the reported info.
Patient Sequence No: 1, Text Type: N, H10


[62390608] Integra has completed their internal investigation on 07/13/2015. Methods, review of device history records, review of complaint history - results: no product samples, nor support documentation, were retuned to the manufacturer. No product was retuned to the manufacturer. Additionally, the lot number of the product was not confirmed. The orthoblast 11 paste product is suspected to be manufactured under lot number 141899. The complete device history record was reviewed and no anomalies were noted. The product was manufactured and released in accordance with product specifications. The demineralization record for the demineralized bone used in lot number 141899 was reviewed and no anomalies were noted. The applicable donor files were reviewed and no anomalies were noted. All donors are prescreened by a medical director at our tissue bank for serology and microbial cultures. A retain sample was reviewed and no anomalies were detected. The complaint database was reviewed for the last two years and such review indicated there were no other related complaints for this product. Conclusion: no product was returned to the manufacturer. Additionally, the lot number of the product was not confirmed. The orthoblast il paste product is "suspected" to be manufactured under lot number 141899. The complete device history record was reviewed and no anomalies were noted. The product was not used as intended osteolysis cannot be determined in such a short time period in accordance with the directions for use which states "sites grafted with orthoblast 11 should be allowed to heal approximately 6 months prior to implant placement. " resultantly, no root cause could be determined.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2090010-2015-00006
MDR Report Key4691853
Report Source01,06,07,08,COMPANY REPRESENT
Date Received2015-04-13
Date of Report2015-03-16
Date Mfgr Received2015-03-16
Date Added to Maude2015-04-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMARIA LEONARD
Manufacturer Street311 ENTERPRISE DR
Manufacturer CityPLAINSBORO NJ 08536
Manufacturer CountryUS
Manufacturer Postal08536
Manufacturer Phone6099362341
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameORTHOBLAST-II PASTE
Generic NameORTHOBLAST
Product CodeMBP
Date Received2015-04-13
Catalog Number02-2100-010
Lot Number141899 (SUSPECTED LOT)
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerISOTIS ORTHOBIOLOGICS, INC
Manufacturer AddressIRVINE CA 92618 US 92618


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2015-04-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.